C
AGIO icon

Covestor’s Agios Pharmaceuticals AGIO Stock Holding History

Covestor’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Buy
12
+9
+300% +$273 ﹤0.01% 2452
2026
Q1 		$0 Sell
3
-38
-93% -$1.08K ﹤0.01% 2204
2025
Q4 		$1K Sell
41
-23
-36% -$807 ﹤0.01% 1976
2025
Q3 		$3K Buy
64
+61
+2,033% +$2.29K ﹤0.01% 1872
2025
Q2 		$0 Hold
3
– – ﹤0.01% 2151
2025
Q1 		$0 Sell
3
-2
-40% -$66 ﹤0.01% 2160
2024
Q4 		$0 Hold
5
– – ﹤0.01% 2181
2024
Q3 		$0 Sell
5
-7
-58% -$318 ﹤0.01% 2156
2024
Q2 		$1K Buy
12
+8
+200% +$289 ﹤0.01% 1910
2024
Q1 		$0 Sell
4
-7
-64% -$187 ﹤0.01% 2186
2023
Q4 		$0 Buy
11
+2
+22% +$45 ﹤0.01% 2085
2023
Q3 		$0 Buy
9
+4
+80% +$106 ﹤0.01% 2051
2023
Q2 		$0 Hold
5
– – ﹤0.01% 2068
2023
Q1 		$0 Hold
5
– – ﹤0.01% 1945
2022
Q4 		$0 Sell
5
-2
-29% -$56 ﹤0.01% 1991
2022
Q3 		$0 Buy
+7
New +$188 ﹤0.01% 1916

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Covestor's AGIO Position: Q2 2026 in Review

Covestor increased its Agios Pharmaceuticals (AGIO) stake by 300% in Q2 2026, buying an estimated $273 and bringing the position to 12 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2452.

Covestor first reported a position in AGIO in Q3 2022 and has held it in 16 quarters since. The position peaked at $3K in Q3 2025. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Covestor held 12 shares of Agios Pharmaceuticals worth $0 as of Q2 2026.
  • Covestor bought 9 Agios Pharmaceuticals shares in Q2 2026, an estimated $273.
  • Agios Pharmaceuticals made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2452 holding.
  • Covestor first reported a position in Agios Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
  • Covestor's Agios Pharmaceuticals position peaked at $3K in Q3 2025.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.